Glenmark Life Sciences listing: No bumper gains; shares debut at 4% premium to IPO price
OnGlenmark Life Sciences shares made a weak listing on the stock exchanges today, marred by the muted market momentum. Glenmark Life Sciences32% from the.
Read More